Skip to main content

Table 1 Results of mutation analysis in 25 patients with pathogenic or likely pathogenic mutations involving single nucleotide or several exons according to ACMG guideline

From: Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing

Patient

Gene

Inheritance

NM

Nucleotide change

Amino acid change

Zygosity

ACMG classification

ACMG evidence components

Origin of variant

P1

STXBP1

AD

NM_003165.3

c.733C > G

p.His245Asp

Heterozygosity

Pathogenic

PS2, PM2, PM5, PP3, PP4

de novo

P2

STXBP1

AD

NM_003165.3

c.874C > T

p.Arg292Cys

Heterozygosity

Pathogenic

PS1, PS2, PM2, PP4

de novo

P3

STXBP1

AD

NM_003165.3

c.1216C > T

p.Arg406Cys

Heterozygosity

Pathogenic

PS1, PS2, PM2, PM5, PP3, PP4

de novo

P4

CDKL5

XD

NM_003159.2

c.511 T > A

p.Tyr171Asn

Heterozygosity

Pathogenic

PS2, PM2, PM5, PP3, PP4

de novo

P5

CDKL5

XD

NM_003159.2

c.282 + 1G > A

splice site

Heterozygosity

Pathogenic

PVS1, PS2, PM2, PP4, PP5

de novo

P6

KCNQ2

AD

NM_172107.2

c.917C > T

p.Ala306Val

Heterozygosity

Pathogenic

PS2, PM2, PP2, PP3, PP4, PP5

de novo

P7

KCNQ2

AD

NM_172107.2

c.593G > A

p.Arg198Gln

Heterozygosity

Pathogenic

PS2, PM2, PP2, PP3, PP4, PP5

de novo

P8

SCN1A

AD

NM_001165963.1

c.5068_5069delinsG

p.Ser1690AlafsTer25

Heterozygosity

Pathogenic

PVS1, PM2, PP4

NA

P9

SCN1A

AD

NM_001165963.1

c.1209dupT

p.Val404CysfsTer46

Heterozygosity

Pathogenic

PVS1, PM2, PP4

NA

P10

SYNGAP1

AD

NM_006772.2

c.980 T > C

p.Leu327Pro

Heterozygosity

Likely pathogenic

PS2, PM2, PP3, PP4, PP5

de novo

P11

SYNGAP1

AD

NM_006772.2

c.1735C > T

p.Arg579Ter

Heterozygosity

Pathogenic

PVS1, PM2, PP4, PP5

NA

P12

GNAO1

AD

NM_020988.2

c.118G > T

p.Gly40Trp

Heterozygosity

Pathogenic

PS2, PM2, PM5, PP3, PP4

de novo

P13

GNAO1

AD

NM_020988.2

c.155A > C

p.Gln52Pro

Heterozygosity

Likely pathogenic

PS2, PM2, PP3, PP4

de novo

P14

KCNT1

AD

NM_020822.2

c.2800G > A

p.Ala934Thr

Heterozygosity

Likely pathogenic

PS1, PM2, PP4

NA

P15

KCNT1

AD

NM_020822.2

c.1038C > G

p.Phe346Leu

Heterozygosity

Likely pathogenic

PS2, PM2, PP2, PP4

de novo

P16

BRAT1

AR

NM_152743.3

c.1576C > T

p.Gln526Ter

Heterozygosity

Likely pathogenic

PVS1, PM2, PP4

maternal inheritance

P16

BRAT1

AR

NM_152743.3

exon 2–3 deletion

_

Heterozygosity

Likely pathogenic

PM2, PM3, PP4, PP5

NA

P17

WWOX

AR

NM_016373.2

c.1060C > T

p.Gln354Ter

Heterozygosity

Pathogenic

PVS1, PM2, PM3, PP4

maternal inheritance

P17

WWOX

AR

NM_016373.2

exon 6–8 duplication

_

Heterozygosity

Likely pathogenic

PM2, PM3, PP4, PP5

paternal inheritance

P18

ZEB2

AD

NM_014795.3

c.1956C > A

p.Tyr652Ter

Heterozygosity

Pathogenic

PVS1, PS1, PM2, PP4

NA

P19

CHD2

AD

NM_001271.3

c.1269dupA

p.Glu424ArgfsTer3

Heterozygosity

Pathogenic

PVS1, PM2, PP4

NA

P20

PRICKLE2

AD

NM_198859.3

c.2129_2147del

p.Arg710LeufsTer2

Heterozygosity

Likely pathogenic

PVS1, PM2

NA

P21

COL4A1

AD

NM_001845.4

c.2897G > A

p.Gly966Glu

Heterozygosity

Likely pathogenic

PS2, PM2, PP2, PP3, PP4

de novo

P22

DNM1

AD

NM_004408.2

c.1195A > G

p.Arg399Gly

Heterozygosity

Likely pathogenic

PS2, PM2, PP2, PP3, PP4

de novo

P23

SCN8A

AD

NM_014191.3

c.782G > T

p.Cys261Phe

Heterozygosity

Likely pathogenic

PS2, PM2, PP2, PP3, PP4

de novo

P24

MECP2

XD

NM_004992.3

c.1164_1207del

p.Pro389Ter

Heterozygosity

Pathogenic

PVS1, PM1, PM2, PP4

NA

P25

SLC9A6

XD

NM_006359.2

c.316_325 + 28del

splice site

Heterozygosity

Pathogenic

PVS1, PS2, PM2, PP4

de novo

  1. AD autosomal dominant, XD X dominant, AR autosomal recessive, VUS variant of unknown significance, PVS pathogenic very strong, PS pathogenic strong, PM pathogenic moderate, PP pathogenic supporting, NA not available